Role of p21-activated kinases in cardiovascular development and function

Cellular and Molecular Life Sciences

Volumn 70, Issue 22, 2013, Pages 4223-4228

  Kelly, Mollie L ^a,b   Astsaturov, Artyom ^b   Chernoff, Jonathan ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Cardiovascular; Model organisms; Protein kinases; Signal transduction; Small GTPases

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR AGENT; FINGOLIMOD; LIM KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN KINASE; P21 ACTIVATED KINASE; P21 ACTIVATED KINASE 1; P21 ACTIVATED KINASE 2; P21 ACTIVATED KINASE 4; P21 ACTIVATED KINASE INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE B; UNCLASSIFIED DRUG; ISOPROTEIN; PROTEIN KINASE INHIBITOR;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DEVELOPMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HEART DEVELOPMENT; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE CONTRACTILITY; HUMAN; MORPHOGENESIS; NONHUMAN; ORGANOGENESIS; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR DISEASES; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

DANIO RERIO; MUS;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; P21-ACTIVATED KINASES; PROTEIN ISOFORMS; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 84887054594     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1347-8     Document Type: Review

References (31)

1. Ai X, Jiang A, Ke Y, Solaro RJ, Pogwizd SM (2011) Enhanced activation of p21-activated kinase 1 in heart failure contributes to dephosphorylation of connexin 43. Cardiovasc Res 92:106-114
2. Arias-Romero LE, Chernoff J (2008) A tale of two Paks. Biol Cell 100:97-108
3. Birukova AA, Xing J, Fu P, Yakubov B, Dubrovskyi O, Fortune JA, Klibanov AM, Birukov KG (2010) Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. Am J Physiol Lung Cell Mol Physiol 299:L652-L663
4. Bokoch GM (2003) Biology of the p21-activated kinases. Annu Rev Biochem 72:743-781
5. Buchner DA, Su F, Yamaoka JS, Kamei M, Shavit JA, Barthel LK, McGee B, Amigo JD, Kim S, Hanosh AW et al (2007) pak2a mutations cause cerebral hemorrhage in redhead zebrafish. Proc Natl Acad Sci USA 104:13996-14001
6. Chow HY, Jubb AM, Koch JN, Jaffer ZM, Stepanova D, Campbell DA, Duron SG, O'Farrell M, Cai KQ, Klein-Szanto AJ et al (2012) p21-Activated kinase 1 is required for efficient tumor formation and progression in a Ras-mediated skin cancer model. Cancer Res 72:5966-5975
7. Egom EE, Ke Y, Musa H, Mohamed TM, Wang T, Cartwright E, Solaro RJ, Lei M (2010) FTY720 prevents ischemia/reperfusion injury-associated arrhythmias in an ex vivo rat heart model via activation of Pak1/Akt signaling. J Mol Cell Cardiol 48:406-414
8. Gaengel K, Niaudet C, Hagikura K, Lavina B, Muhl L, Hofmann JJ, Ebarasi L, Nystrom S, Rymo S, Chen LL et al (2012) The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev Cell 23:587-599
9. Gavard J, Gutkind JS (2006) VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8:1223-1234
10. Goeckeler ZM, Masaracchia RA, Zeng Q, Chew TL, Gallagher P, Wysolmerski RB (2000) Phosphorylation of myosin light chain kinase by p21-activated kinase PAK2. J Biol Chem 275:18366-18374
11. Higuchi M, Onishi K, Kikuchi C, Gotoh Y (2008) Scaffolding function of PAK in the PDK1-Akt pathway. Nat Cell Biol 10:1356-1364
12. Jung B, Obinata H, Galvani S, Mendelson K, Ding BS, Skoura A, Kinzel B, Brinkmann V, Rafii S, Evans T, Hla T (2012) Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. Dev Cell 23:600-610
13. Ke Y, Lei M, Collins TP, Rakovic S, Mattick PA, Yamasaki M, Brodie MS, Terrar DA, Solaro RJ (2007) Regulation of L-type calcium channel and delayed rectifier potassium channel activity by p21-activated kinase-1 in guinea pig sinoatrial node pacemaker cells. Circ Res 100:1317-1327
14. Ke Y, Lei M, Wang X, Solaro RJ (2012) Novel roles of PAK1 in the heart. Cell Logist 2:89-94
15. Ke Y, Sheehan KA, Egom EE, Lei M, Solaro RJ (2010) Novel bradykinin signaling in adult rat cardiac myocytes through activation of p21-activated kinase. Am J Physiol Heart Circ Physiol 298:H1283-H1289
16. Ke Y, Wang L, Pyle WG, de Tombe PP, Solaro RJ (2004) Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ Res 94:194-200
17. Kelly ML, Chernoff J (2012) Mouse models of PAK function. Cell Logist 2:84-88
18. Kiosses WB, Hood J, Yang S, Gerritsen ME, Cheresh DA, Alderson N, Schwartz MA (2002) A dominant-negative p65 PAK peptide inhibits angiogenesis. Circ Res 90:697-702
19. Koh W, Mahan RD, Davis GE (2008) Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling. J Cell Sci 121:989-1001
20. Koh W, Sachidanandam K, Stratman AN, Sacharidou A, Mayo AM, Murphy EA, Cheresh DA, Davis GE (2009) Formation of endothelial lumens requires a coordinated PKCepsilon-, Src-, Pak- and Raf-kinase-dependent signaling cascade downstream of Cdc42 activation. J Cell Sci 122:1812-1822
21. Kosoff R, Chow HY, Radu M, Chernoff J (2013) Pak2 kinase restrains mast cell Fc{epsilon}RI receptor signaling through modulation of Rho protein guanine nucleotide exchange factor (GEF) activity. J Biol Chem 288:974-983
22. Liu J, Fraser SD, Faloon PW, Rollins EL, Vom Berg J, Starovic-Subota O, Laliberte AL, Chen JN, Serluca FC, Childs SJ (2007) A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish. Proc Natl Acad Sci USA 104:13990-13995
23. Liu W, Zi M, Naumann R, Ulm S, Jin J, Taglieri DM, Prehar S, Gui J, Tsui H, Xiao RP et al (2011) Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart. Circulation 124:2702-2715
24. Mao K, Kobayashi S, Jaffer ZM, Huang Y, Volden P, Chernoff J, Liang Q (2008) Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes. J Mol Cell Cardiol 44:429-434
25. Murray BW, Guo C, Piraino J, Westwick JK, Zhang C, Lamerdin J, Dagostino E, Knighton D, Loi CM, Zager M et al (2010) Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc Natl Acad Sci USA 107:9446-9451
26. Nekrasova T, Minden A (2012) Role for p21-activated kinase PAK4 in development of the mammalian heart. Transgenic Res 21:797-811
27. Oo ML, Thangada S, Wu MT, Liu CH, Macdonald TL, Lynch KR, Lin CY, Hla T (2007) Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem 282:9082-9089
28. Stockton RA, Schaefer E, Schwartz MA (2004) p21-activated kinase regulates endothelial permeability through modulation of contractility. J Biol Chem 279:46621-46630
29. Tang Y, Zhou H, Chen A, Pittman RN, Field J (2000) The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem 275:9106-9109
30. Tian Y, Lei L, Cammarano M, Nekrasova T, Minden A (2009) Essential role for the Pak4 protein kinase in extraembryonic tissue development and vessel formation. Mech Dev 126:710-720
31. Zeng Q, Lagunoff D, Masaracchia R, Goeckeler Z, Cote G, Wysolmerski R (2000) Endothelial cell retraction is induced by PAK2 monophosphorylation of myosin II. J Cell Sci 113(Pt 3):471-482